SynthesisBMC public health2022
Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review.
Synthesis in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.
- The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis.Frontiers in public health · 2024Pooled it
- Prevalence of Sarcopenia in Africa: A Systematic Review.Clinical interventions in aging · 2023Pooled it
- Glycaemic Control, Blood Pressure and Lifestyle Behaviours in Relation to Sarcopenia Among Older Adults in Korea: A Population-Based Cross-Sectional Study.Australasian journal on ageing · 2026Article
- Association of depression with sarcopenia and the impact of sleep: the first longitudinal evidence from the CHARLS.BMC public health · 2026Article
- Development and validation of a screening tool for sarcopenia in community-dwelling older adults: a diagnostic cross-sectional study.BMC geriatrics · 2026Article
- Sarcopenia and satellite cell homeostasis disruption: the dual function of NAD+ metabolism.Frontiers in nutrition · 2026Review
- Altered serum short-chain fatty acids in sarcopenia among Chinese elderly women: a case-control study.BMC geriatrics · 2025Article
- Development and validation of a sarcopenia risk prediction model for community-dwelling older adults.BMC public health · 2025Article
- Bilateral association between muscle strength and depression: evidence from a prospective cohort study.BMC public health · 2025Article
- Prevalence of sarcopenia in patients with surgical obstructive jaundice and its impact on clinical outcomes.World journal of gastrointestinal surgery · 2025Article
- Dyrk1b as a potential biomarker for sarcopenia in older adults.BMC geriatrics · 2025Article
- A predictive nomogram based on triglyceride glucose index to body mass index ratio for low appendicular skeletal muscle mass.Scientific reports · 2025Article
- Effect of Resistance Training on Older Adults with Sarcopenic Obesity: A Comprehensive Systematic Review and Meta-Analysis of Blood Biomarkers, Functionality, and Body Composition.Nursing reports (Pavia, Italy) · 2025Review
- Low serum HSPA12B levels are associated with an increased risk of sarcopenia in a Chinese population of older adults.Cell stress & chaperones · 2025Article
- Prevalence and influencing factors of sarcopenia among older adults in rural coastal areas of Ningbo City.Scientific reports · 2025Article
- The Dietary Inflammatory Index and Sarcopenia in Older Adults in Four Chinese Provinces: A Cross-Sectional Study.Nutrients · 2025Article
- Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies.Frontiers in microbiology · 2025Review
- Association between dietary patterns and sarcopenia among community-dwelling older adults in five provinces of China: a cross-sectional study.Frontiers in public health · 2025Article
- Association Between Serum Magnesium and Muscle Mass in People With Type 2 Diabetes Mellitus.International journal of endocrinology · 2025Article
- Developing a proactive coping theory-based conceptual framework for sarcopenia management in aging societies: a mixed-methods study from China.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia is associated with age-related loss of muscle mass and function and is becoming prevalent in the older Chinese population. This systematic review aims to obtain a reliable estimation of the prevalence of sarcopenia among community-dwelling Chinese populations aged 65 years and older and to characterize its epidemiology.
methodsA literature search was performed in the Cochrane Library, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data, and CQVIP databases up to September 31, 2021. All studies that reported the prevalence of sarcopenia in Chinese community-dwelling older adults were included, and Hoy et al.'s tool was used to assess the risk of bias. The overall prevalence of sarcopenia will be calculated as the primary outcome, and subgroup analyses will be performed by study year, age, sex, muscle mass assessment method, diagnostic criteria and area.
resultsA total of 26 studies were included in this study, which involved 25,921 subjects, and 3597 had sarcopenia. Although significant heterogeneity between studies was reported, no statistically significant publication bias was detected. The overall prevalence of sarcopenia in community-dwelling older adults aged over 65 years in the Chinese population was 17.4% (95% CI: 14.6%-20.2%). Subgroup analysis based on study year, age and sex, muscle mass assessment method, diagnostic criteria, region and area showed that the prevalence of sarcopenia was different in each subgroup. IMPLICATIONS: The prevalence of sarcopenia in Chinese community-dwelling older adults was higher than that in previous studies. As a multidimensional survey of the prevalence of sarcopenia in older adults, this meta-analysis provides data support for the targeted management of sarcopenia among Chinese older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.